Stay updated on ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.

Latest updates to the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedLocations were updated to add new study sites across the US (California, Georgia, Illinois, Kansas, Minnesota, Missouri, New York, Oregon, Pennsylvania, Washington), China (Jiangsu, Sichuan), Italy (Lombardy), South Korea (Gyeonggi-do), the UK (Wirral), and Taiwan, while several prior locations were removed; revision: v3.3.3.SummaryDifference1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe page now displays an updated revision number from v3.2.0 to v3.3.2 in the site's metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedThe government funding/operating status notice has been removed from the page.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded three sites in Tainan, Taiwan (postal codes 704, 71004, 73657) and updated the city designation from 'Tainan City' to 'Tainan'.SummaryDifference0.1%

- Check69 days agoChange DetectedNo substantive changes detected in the study record; the title, conditions, interventions, outcomes, and locations appear unchanged.SummaryDifference0.3%

- Check98 days agoChange DetectedUpgrade to v3.2.0 with an added government-operating-status notice; v3.1.0 was removed. The page now warns that funding lapses may affect updates and transactions.SummaryDifference3%

Stay in the know with updates to ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.